HOME >> MEDICINE >> NEWS
Aspirin and other non-specific COX inhibitors may slow atherosclerosis

Making sure cardiac patients take an aspirin a day to prevent a second heart attack is part of established treatment for most physicians, and many recommend the same regimen for patients at risk of suffering a first attack. But there has never been scientific evidence to demonstrate that this common, over-the-counter medication really provides any benefit in staving off the underlying condition of atherosclerosis.

Now, mouse-model research by scientists at the University of Pennsylvania School of Medicine has demonstrated that aspirin, ibuprofen and other drugs in the class of pharmaceuticals known as non-specific COX inhibitors may aid substantially in preventing heart disease, slowing the build-up of plaque in blood vessels by more than 50 percent.

"This study suggests that a product of the cyclooxegenase enzyme known as COX-1 -- which is the form targeted by aspirin in the prevention of heart attacks -- may also have a part to play in the gradual hardening of the arteries that precedes acute events like heart attack or stroke," said Garret A. FitzGerald, MD, chairman of Penns Department of Pharmacology. The research will be published March 13 in the Proceedings of the National Academy of Science.

The study also demonstrates that a separate class of drugs that specifically target the COX-2 enzyme -- so-called "super aspirins" such as Celebrex and Vioxx -- do not speed up the development of atherosclerosis, a concern based on some biochemical effects of those drugs. In their work, the Penn scientists scrutinized both known forms of the enzyme cyclooxygenase: COX-1, which is present throughout the body, and COX-2, which is present in some tissues, including the lining of the blood vessels.

COX-1 is the only form of the enzyme in platelets -- blood cells that stick together in the first stages of clotting. Suppression of the platelet COX-1 product, thromboxane, is how aspirin protects against heart attack and stroke.

The COX-2 enzyme produc
'"/>

Contact: Ellen O'Brien
ellen.obrien@uphs.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
6-Mar-2001


Page: 1 2 3

Related medicine news :

1. Aspirins potential ability to prevent colon polyps may not apply equally to all
2. Aspirin underused to reduce heart disease risk in diabetic women and young adults
3. Long Island Breast Cancer Study data: Aspirin helps protect some women against breast cancer
4. Aspirin use associated with reduced risk of breast cancer
5. Aspirin use may be associated with increased risk of pancreatic cancer
6. Aspirin is most cost effective way to prevent heart disease
7. Aspirin withdrawal may pose risk to coronary patients
8. Aspirin does not reduce effectiveness of ACE inhibitors
9. Aspirin may help prevent pancreatic cancer
10. Aspirins target, the COX-2 enzyme, linked to cancer of the uterus
11. Aspirin within two days of ischemic stroke reduces deaths

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2019)... ... 23, 2019 , ... Southern Illinois University School of Dental Medicine (SIU SDM) ... receiving their doctor of dental medicine degrees at the SDM’s commencement ceremony at 10 ... ceremony can be viewed live on siue.edu/tv. , In 1976, the SDM hired Savoca ...
(Date:5/22/2019)... Mass. (PRWEB) , ... May 22, 2019 , ... ... rates by 55% between Q1 of 2018 and Q1 of 2019 due to ... Health Recovery Solutions (HRS). In addition to this steep reduction in readmissions, Community ...
(Date:5/22/2019)... ONTARIO, Calif. (PRWEB) , ... May 22, 2019 ... ... President of Avante Ultrasound, announced the implementation of a common management structure that ... , Ultra Solutions’ location in Ontario, Calif. has become Avante Ultrasound’s west coast ...
(Date:5/22/2019)... ... May 22, 2019 , ... EY today ... is a finalist for the Entrepreneur Of The Year® 2019 Award in the ... in the U.S., the program recognizes entrepreneurs and leaders of high-growth companies who ...
(Date:5/22/2019)... ST. LOUIS (PRWEB) , ... May 22, 2019 ... ... announced a new annual health observance, National Lifestyle Medicine Week, to take place ... employing each of the evidence-based therapeutic approaches of Lifestyle Medicine: a whole food, ...
Breaking Medicine News(10 mins):
(Date:5/22/2019)... ... 2019 , ... New research places Fort Worth in the top 20 percent ... in 2013. According to the Gallup National Health and Well-Being Index, Fort Worth’s 2019 ... Fort Worth’s equivalent rank was 185th out of 190 reported metro areas. Last year, ...
(Date:5/22/2019)... ... May 22, 2019 , ... RoosterBio, Inc, ... exhibit and present at the International Society for Cell &Gene Therapy (ISCT) Annual ... company is also hosting several events including:, , Wednesday, ...
(Date:5/22/2019)... , ... May 22, 2019 , ... Ahead of the ... announced today its partnership with Osmosis, the leading medical education platform with more than ... education industry. With an impending shortage of more than 120,000 clinicians by 2030, the ...
Breaking Medicine Technology:
Cached News: